重症急性胰腺炎治愈出院患者远期生活质量现状调查及影响因素分析
该回顾性研究纳入2017年1月至2023年12月在安徽医科大学第二附属医院重症医学科一科接受规范化治疗并治愈出院的86例重症急性胰腺炎(SAP)患者,按SF-36总分前50%与后50%分为高分组与低分组各43例。随访发现23.26%复发急性胰腺炎,25.58%出院后慢性腹痛,38.37%胰腺外分泌功能障碍,25.58%胰腺内分泌功能障碍并诊断为糖尿病。多因素Logistic回归显示高血压(OR=4.814,95%CI 1.196-19.378)、入院血清钙<2.0 mmol/L(OR=6.688,95%CI 1.321-33.873)、入院血糖>11.1 mmol/L(OR=6.473,95%CI 1.399-29.950)为远期低生活质量的危险因素,出院后预防性干预为保护因素(OR=0.092,95%CI 0.020-0.425,P<0.01)。作者认为针对胰腺炎病因的出院后预防和干预可改善治愈SAP患者的远期生活质量。
要点
- 86例治愈出院SAP患者中,20例(23.26%)复发急性胰腺炎,22例(25.58%)出院后慢性腹痛,其中5例(5.81%)需药物缓解疼痛。
- 33例(38.37%)出院后存在胰腺外分泌功能障碍(腹胀、便秘或腹泻),22例(25.58%)存在胰腺内分泌功能障碍并诊断为糖尿病。
- 多因素分析:高血压(OR=4.814,95%CI 1.196-19.378)、入院血清钙<2.0 mmol/L(OR=6.688,95%CI 1.321-33.873)、入院血糖>11.1 mmol/L(OR=6.473,95%CI 1.399-29.950)为远期低生活质量危险因素(均P<0.05)。
- 出院后预防性干预是远期生活质量的保护因素(OR=0.092,95%CI 0.020-0.425,P<0.01)。
- 单因素分析中低分组较高分组更多合并高血压(48.84% vs. 16.28%)、入院肾功能不全(60.47% vs. 32.56%)、入院重度代谢性酸中毒(18.60% vs. 4.65%)、入院血清钙<2.0 mmol/L(88.37% vs. 62.79%)、血糖>11.1 mmol/L(55.81% vs. 30.23%)及培养出革兰阳性菌(34.88% vs. 13.95%),CTSI更高
适用人群与场景
- 2017年1月至2023年12月收治于安徽医科大学第二附属医院重症医学科一科、接受规范化治疗并治愈出院的SAP患者。
- 最终纳入86例,按SF-36总分前50%(高分组)与后50%(低分组)各43例。
诊断标准与关键阈值
- 采用36条目简明健康调查量表(SF-36)总分分组:总分前50%为高分组(高生活质量),后50%为低分组(低生活质量)。
研究设计与关键结果
- 回顾性收集86例治愈出院SAP患者,高分组与低分组各43例;20例(23.26%)复发急性胰腺炎,22例(25.58%)出院后慢性腹痛(其中5例(5.81%)需药物缓解疼痛),33例(38.37%)胰腺外分泌功能障碍(腹胀、便秘或腹泻),22例(25.58%)胰腺内分泌功能障碍并诊断为糖尿病。
- 单因素分析:低分组较高分组更多合并高血压(48.84% vs. 16.28%)、入院肾功能不全(60.47% vs. 32.56%)、入院重度代谢性酸中毒(18.60% vs. 4.65%)、入院血清钙<2.0 mmol/L(88.37% vs. 62.79%)、血糖>11.1 mmol/L(55.81% vs. 30.23%)、治疗期间培养出革兰阳性菌(血/体液/胰腺坏死组织)(34.88% vs. 13.95%),CTSI评分更高(6.60±1.61 vs. 5.77±1.32),出院时血红蛋白更低(102.30±18.78 g/L vs. 110.72±16.68 g/L),出院后病因干预比例更低(34.88% vs. 67.44%),差异均有统计学意义(均P<0.05)。
- 多因素Logistic回归:高血压(OR=4.814,95%CI 1.196-19.378)、入院血清钙<2.0 mmol/L(OR=6.688,95%CI 1.321-33.873)、入院血糖>11.1 mmol/L(OR=6.473,95%CI 1.399-29.950)为治愈SAP患者远期低生活质量的危险因素(均P<0.05);出院后预防性干预为保护因素(OR=0.092,95%CI 0.020-0.425,P<0.01)。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,针对胰腺炎病因的出院后预防和干预可改善治愈SAP患者的远期生活质量。
- 对合并高血压、入院血清钙<2.0 mmol/L、入院血糖>11.1 mmol/L的治愈出院SAP患者,远期生活质量可能较低,出院后需关注胰腺外分泌与内分泌功能及复发风险。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the current status of long-term quality of life in patients with severe acute pancreatitis (SAP) who have been cured and discharged, and to analyze the influencing factors affecting long-term quality of life in SAP cured patients after discharge.
METHODS: A retrospective collection was conducted. Patients who were received standardized treatment before being cured and discharged from the hospital admitted to the first department of critical care medcine of the Second Affiliated Hospital of Anhui Medical University from January 2017 to December 2023 were enrolled. According to the 36-item short form health survey scale (SF-36) score, patients were divided into high score group (high quality of life, the top 50% of patients with total SF-36 score) and low score group (low quality of life, the bottom 50% of patients with total SF-36 score). The gender, age, history of hypertension and diabetes, etiology of pancreatitis, acute physiology and chronic health evaluation II (APACHE II), sequential organ failure assessment (SOFA), CT severity index (CTSI), laboratory indicators such as C-reactive protein (CRP), procalcitonin (PCT), blood glucose, and triglycerides upon admission, use of vasoactive drugs, non-invasive/high-flow ventilation, invasive ventilation, retroperitoneal puncture and drainage, open pancreatic surgery treatment and secondary infection during hospitalization were collected, as well as the retention of abdominal drainage tubes at discharge from hospital. Distribute follow-up questionnaires or telephone follow-up surveys through WeChat and Question Star programs to investigate the pancreatic secretion function, chronic abdominal pain, and recurrence of pancreatitis of patients after discharge. Multivariable Logistic regression was used to analyze the relevant factors affecting the long-term quality of life of cured patients with SAP.
RESULTS: A total of 86 patients were ultimately enrolled. There were 43 patients in both the high and low score groups. Among 86 patients, 20 experienced acute pancreatitis recurrence, with a recurrence rate of 23.26%. Twenty-two (25.58%) experienced chronic abdominal pain after discharge, and 5 patients (5.81%) needed medication to relieve pain. Thirty-three patients (38.37%) had pancreatic exocrine dysfunction after discharge, characterized by abdominal distension, constipation or diarrhea. Twenty-two patients (25.58%) suffered from pancreatic endocrine dysfunction, and were diagnosed with diabetes. Univariate analysis showed that compared with the high score group, the low score group had more patients with hypertension, initial renal dysfunction, initial severe metabolic acidosis, initial serum calcium < 2.0 mmol/L, blood glucose > 11.1 mmol/L and cultured Gram positive bacteria (from blood/body fluid/pancreatic necrotic tissue) during treatment (48.84% vs. 16.28%, 60.47% vs. 32.56%, 18.60% vs. 4.65%, 88.37% vs. 62.79%, 55.81% vs. 30.23%, 34.88% vs. 13.95%), had higher CTSI score (6.60±1.61 vs. 5.77±1.32), lower hemoglobin level at discharge (g/L: 102.30±18.78 vs. 110.72±16.68), and a lower proportion of etiological interventions after discharge (34.88% vs. 67.44%), the differences were statistically significant (all P < 0.05). Multivariate Logistic regression analysis showed that hypertension [odds ratio (OR) = 4.814, 95% confidence interval (95%CI) was 1.196-19.378], initial serum calcium < 2.0 mmol/L (OR = 6.688, 95%CI was 1.321-33.873) and initial blood glucose > 11.1 mmol/L (OR = 6.473, 95%CI was 1.399-29.950) were risk factors for long-term quality of life in cured SAP patients (all P < 0.05), while post discharge prophylactic intervention was a protective factor for long-term quality of life (OR = 0.092, 95%CI was 0.020-0.425, P < 0.01).
CONCLUSIONS: Cured SAP patients have varying degrees of impaired secretion function and the possibility of recurrence of acute pancreatitis. Hypertension, initial serum calcium < 2.0 mmol/L and blood glucose > 11.1 mmol/L are independent influencing factors for low long-term quality of life in cured SAP patients. Prevention and intervention targeting the etiology of pancreatitis after discharge can improve the long-term quality of life of cured SAP patients.
参考来源
- Zhou W, Zhang P, Yu W, et al. [Current situation investigation and analysis of influencing factors on the long-term quality of life of cured and discharged patients with severe acute pancreatitis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 40017362. doi:10.3760/cma.j.cn121430-20240626-00540
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。